The chemoprophylaxis of malaria.
Chiodini
P L
PL
Hospital for Tropical Diseases, London, UK.
D000655:Amodiaquine / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D002738:Chloroquine / Q000627:therapeutic use; D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004351:Drug Resistance; D008288:Malaria / Q000517:prevention & control*; D010963:Plasmodium falciparum; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000009:adverse effects / Q000627:therapeutic use; D013413:Sulfadoxine / Q000009:adverse effects / Q000627:therapeutic use
D004338:Drug Combinations; D000655:Amodiaquine; C001205:fanasil, pyrimethamine drug combination; C001678:Maloprim; D013413:Sulfadoxine; D002738:Chloroquine; D003622:Dapsone; D002727:Proguanil; D011739:Pyrimethamine